Amicus Therapeutics (FOLD) Return on Equity (2016 - 2025)
Historic Return on Equity for Amicus Therapeutics (FOLD) over the last 16 years, with Q3 2025 value amounting to 0.06%.
- Amicus Therapeutics' Return on Equity rose 6100.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 6100.0%. This contributed to the annual value of 0.32% for FY2024, which is 7500.0% up from last year.
- Per Amicus Therapeutics' latest filing, its Return on Equity stood at 0.06% for Q3 2025, which was up 6100.0% from 0.19% recorded in Q2 2025.
- In the past 5 years, Amicus Therapeutics' Return on Equity ranged from a high of 0.06% in Q3 2025 and a low of 1.85% during Q4 2022
- In the last 5 years, Amicus Therapeutics' Return on Equity had a median value of 0.99% in 2022 and averaged 0.99%.
- In the last 5 years, Amicus Therapeutics' Return on Equity plummeted by -11200bps in 2022 and then surged by 8600bps in 2025.
- Amicus Therapeutics' Return on Equity (Quarter) stood at 0.73% in 2021, then plummeted by -153bps to 1.85% in 2022, then soared by 44bps to 1.03% in 2023, then soared by 71bps to 0.3% in 2024, then skyrocketed by 79bps to 0.06% in 2025.
- Its last three reported values are 0.06% in Q3 2025, 0.19% for Q2 2025, and 0.15% during Q1 2025.